Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Cell Physiol. 2012 Dec;227(12):3715–3721. doi: 10.1002/jcp.24098

Figure 3. Relationship between mRNA levels of Par-4 and patient survival.

Figure 3

(A) Oncomine anaylsis indicated increased Par-4 mRNA levels correlate with decreased survival in squamous cell lung carcinoma patients (logrank P = 0.061). Survival time in patients with lung adenocarcinoma shows no significant correlation with mRNA levels of Par-4 (logrank P = 0.94).

(B) A composite of multiple data sets from Oncomine depicting 1 year survival status in patients with squamous cell carcinoma and adenocarcinoma of the lung. The colored squares represent data from different studies.